Pristine Surgical

Executive Summary

Pristine Surgical is a medical device company founded in 2017 and headquartered in Austin, Texas, with a mission to simplify endoscopy. The company has developed a platform that combines single-use endoscopes with cloud-based software, aiming to make minimally invasive visualization more efficient, consistent, and safe. By eliminating the need for reprocessing, their single-use scopes reduce infection risk and operational complexity, while the cloud software enables remote collaboration, data capture, and analytics. Pristine Surgical targets the growing demand for disposable endoscopy solutions in surgical and diagnostic settings, addressing concerns over cross-contamination and equipment downtime in hospitals and ambulatory surgery centers. The single-use endoscopy market is expanding rapidly, driven by infection control mandates and cost-efficiency pressures. Pristine Surgical differentiates itself through integrated software that enhances workflow and clinical outcomes. The company is well-positioned to capture market share as healthcare providers increasingly adopt disposable devices. With a strong focus on R&D and strategic partnerships, Pristine Surgical is poised for growth, though it faces competition from established players like Boston Scientific and Ambu. Near-term milestones, including regulatory clearances and commercial launches, are expected to accelerate adoption and drive revenues.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation single-use endoscope70% success
• Q4 2026Commercial partnership with a major hospital network60% success
• Q4 2026Series B funding round80% success